Table 2.
Outcomes in the Hard ASCVD cohort (n=5,059; 155 events) |
BAC = 0 mg n=3,721 (73.5%) |
BAC > 0 mg n=1,338 (26.5%) |
p | ||
---|---|---|---|---|---|
Num events | Age-adjusted rate per 1,000 person-years |
Num events | Age-adjusted rate per 1,000 person-years |
||
Acute myocardial infarction | 33 | 1.31 | 18 | 1.75 | 0.09 |
Ischemic stroke | 50 | 2.00 | 27 | 2.74 | 0.04 |
CVD death | 15 | 0.58 | 18 | 1.65 | 0.0003 |
Any of the above | 95 | 3.81 | 60 | 5.96 | 0.0002 |
Outcomes in the Global CVD cohort (n=5,035; 427 events) |
BAC = 0 mg n=3,704 (73.6%) |
BAC > 0 mg n=1,331 (26.4%) |
p | ||
Ischemic heart disease (acute myocardial infarction + coronary angioplasty/stent/bypass graft surgery) | 44 | 1.78 | 20 | 2.01 | 0.25 |
Cerebrovascular disease (ischemic stroke + hemorrhagic stroke) | 71 | 2.84 | 36 | 3.54 | 0.048 |
Heart failure | 66 | 2.47 | 33 | 2.77 | 0.08 |
Cardiomyopathy | 5 | 0.20 | 6 | 0.61 | 0.03 |
Deep vein thrombosis\pulmonary embolism | 24 | 0.88 | 16 | 1.29 | 0.04 |
Cardiac arrest | 2 | 0.08 | 3 | 0.30 | 0.09 |
Peripheral arterial disease | 95 | 3.89 | 46 | 4.82 | 0.04 |
Retinal vascular occlusion | 2 | 0.07 | 4 | 0.31 | 0.04 |
CVD Death | 15 | 0.58 | 17 | 1.56 | 0.0006 |
Any of the above | 281 | 11.45 | 146 | 14.63 | <.0001 |
BAC: breast arterial calcification; CVD: cardiovascular disease; ASCVD: atherosclerotic cardiovascular disease.